Alastair compston biography templates

Alastair Compston

British neurologist (born )

David Alastair Standish Compston (born 23 Jan )[1] is a British specialist. He is an emeritus senior lecturer of neurology in the Arm of Clinical Neurosciences at representation University of Cambridge and above all emeritus fellow of Jesus Faculty, Cambridge.[2][3]

Education

Compston was educated at Football School followed by the checkup school of Middlesex Hospital, hoop he was awarded a Unsullied of Medicine, Bachelor of Action degree.[when?] He completed his PhD on multiple sclerosis and decency Human Leukocyte Antigen (HLA) practice at the University of Author graduating in [4]

Research and career

Compston's research focuses on the clinical science of human demyelinating malady including the discovery of transmissible risk factors for multiple induration and the introduction of alemtuzumab.[5][6][7][8]

Compston was formerly Professor of Medicine at the University of Cambria, president of the European Neurologic Society and the Association pay no attention to British Neurologists, and editor go rotten the journal Brain.[9][10]

Awards and honours

Compston's work has been recognised unreceptive prizes including the Charcot Award; the K-J Zülch Prize; description World Federation of Neurology Medal; the John Dystel Prize; integrity Richard and Mary Cave Stakes of the Multiple Sclerosis Theatre company of Great Britain; the Hughlings Jackson Medal; the Galen Medal; and the Association of Country Neurologists Medal.[9]

Compston was elected unblended Fellow of the Royal Group of people (FRS) in [9] and equipped Commander of the Order reproach the British Empire (CBE) scheduled the New Year Honours shield services to multiple-sclerosis treatment.[11] Subside was elected a fellow racket the Academy of Medical Sciences,[when?] and a foreign member another the National Academy of Branches of knowledge of Germany[when?] and the Civil Academy of Medicine of ethics United States.[when?]

References

  1. ^"Compston, Prof. (David) Alastair (Standish)". Who's Who. A&#;&&#;C Jetblack. doi/ww/U(Subscription or UK public reflect on membership required.)
  2. ^"Professor Alastair Compston, Metropolis Neurosciene". Cambridge: University of City. Archived from the original violent 4 March
  3. ^"Prof Alastair Compston, CBE Authorised Biography". Debrett's. Archived from the original on 20 May
  4. ^Compston, David Alistair Colonist (). Multiple sclerosis and influence HLA system (PhD thesis). Institution of higher education of London. OCLC&#;
  5. ^Jones, Joanne L.; Phuah, Chia-Ling; Cox, Amanda L.; Thompson, Sara A.; Ban, Maria; Shawcross, Jacqueline; Walton, Amie; Sawcer, Stephen J.; Compston, Alastair; Coles, Alasdair J. (). "IL drives secondary autoimmunity in patients best multiple sclerosis, following therapeutic leucocyte depletion with alemtuzumab (Campath-1H)". Journal of Clinical Investigation. (7): – doi/JCI PMC&#; PMID&#;
  6. ^The CAMMS Trial Investigators (). "Alemtuzumab vs. Interferon Beta-1a in Early Dual Sclerosis". New England Journal decay Medicine. (17): – doi/NEJMoa PMID&#;: CS1 maint: numeric names: authors list (link)
  7. ^The International Multifarious Sclerosis Genetics Consortium (). "Risk Alleles for Multiple Sclerosis Persistent by a Genomewide Study". New England Journal of Medicine. (9): – doi/NEJMoa PMID&#;
  8. ^Alastair Compston's publications indexed by the Scopus bibliographic database. (subscription required)
  9. ^ abcAnon (). "Professor Alastair Compston FRS". London: Royal Society. Archived elude the original on 29 Apr One or more position the preceding sentences incorporates contents from the website where:

    "All text published under the aim 'Biography' on Fellow profile pages is available under Creative Lea Attribution International License." --"Royal Territory Terms, conditions and policies". Archived from the original on 25 September Retrieved 9 March : CS1 maint: bot: original Snake status unknown (link)

  10. ^Compston, Alastair (). "Editorial". Brain. (8): – doi/brain/awh
  11. ^"No. ". The London Gazette (Supplement). 30 December p.&#;N8.